🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

LIVE from #ICO2024 🎥"We had to redefine how we think about obesity" SOPHIA coordinator Carel Le Roux from University College Dublin speaks about our transformative research in the field of #obesity care at the ICO SOPHIA symposium in Sao Paulo, Brazil 🇧🇷

Congrats to a successful SOPHIA symposium at #ICO2024 💥 Carel Le Roux, Miroslava Guadjardo, Ebaa Al Ozairi, Werd Al-Najim and Elena Startseva represented the entire SOPHIA consortium at our symposium in Sao Paulo, Brazil 🇧🇷🌎

Prof Carel Le Roux remarked that patients are generally very optimistic about the potential for personalised obesity medicine but also raise a number of legitimate concerns that will be of interest to clinicians, industry, and policy makers sciencedirect.com/science/articl… Innovative Health Initiative

🚨 New Study Alert! 🚨 “Patient perspectives on personalised medicine for obesity: An IMI2 project” highlights the importance of patient involvement in developing obesity treatments Dr Emma Farrell Carel Le Roux Joe Nadglowski Dr Dee McGillicuddy Eva Hollmann sciencedirect.com/science/articl…

Important work from SOPHIA partner EASO 👏

"A complex lived experience" - Dr Dee McGillicuddy speaks with Werd Al-Najim from University College Dublin about the importance of the patient experience in obesity research and how this helps us improve obesity care 💚 Find out more here imisophia.eu

"The right tool at the right moment" - Francois Pattou from CHU de Lille discusses how our SOPHIA federated database gives him the power to securely combine and analyse patient data with scientists and data sources across Europe 🌍🖥️ Find out more here imisophia.eu

“What would be left of me?” Patient perspectives on the risks of obesity treatment: An imisophia qualitative study by Dr Emma Farrell Joe Nadglowski Eva Hollmann Carel Le Roux and Dr Dee McGillicuddy sciencedirect.com/science/articl…

What influences patient decisions when selecting an obesity treatment? by Hilary, David Wally, and Prof Carel Le Roux sciencedirect.com/science/articl…

Did you know that obesity is also prevalent among those with type 1 diabetes?📣 Our latest IMI_SOPHIA publication assesses the prevalence of overweight and #obesity in those with and without #T1D in Belgium, Kuwait and Mexico. sciencedirect.com/science/articl…

"For me, as a clinician, that's going to change how I treat patients" 👨‍⚕️🩺 Dr. Carel Le Roux from University College Dublin talks about how we're working to find the predictors of risk and response for those living with #obesity - and how this impacts patient care. imisophia.eu

Phentyping #obesity has always been challenging. In this very interesting paper Nature Medicine , the imisophia team identify clusters based on easily measured biomarkers and linked the clusters to the risk of T2 #diabetes and CVD nature.com/articles/s4159…

It's here! Our major SOPHIA findings have been published in Nature Medicine 📣🩺SOPHIA researchers have separated obesity into 5 distinct subtypes of obesity - each with differing health consequences and treatment implications Read more here: lnkd.in/eXprs2ZZ

Congrats to SOPHIA PhD fellow Lucas Schreurs 🌠 who won an award for Best New Investigator Poster Research Presentation at 2024 ISPOR in Barcelona 🏆 see it here ispor.org/heor-resources… and stay tuned for our SOPHIA Blueprint for Change report, coming soon! Third-i

Congrats to Francois Pattou and team for their research identifying two distinct subtypes of MASLD – liver-specific and cardiometabolic – each with distinct risk profiles📢 find out more in Nature Medicine

Today, on #WorldObesityDay, there's a spotlight on the systems—not people—that need to change. SOPHIA brings together HCPs, academia, industry leaders, civil society and patient organisations to optimise the future of obesity care. #WOD2025 #ChangingSystems #HealthForAll

Obesity is complex, chronic disease - and a driver of other diseases. Taking action is a critical step to reduce the burden of diabetes, heart disease and cancer. This #WorldObesityDay, we're showing our support for a major system shift to build a healthier future 💚 #WOD2025

We’re looking forward to #ECO2025 in Malaga 🇪🇸 stay tuned for more information about our SOPHIA symposium!

Find the @IMI_SOPHIA banner on the front page of your #ECO2025 app 📱 read about our symposium on 14 May and click through to see our key consensus statements on #obesity costs, care and the future of research. imisophia.eu/key-messages-o…

Join us for our #ECO2025 SOPHIA symposium! 📣 Hear NeleSteenackers, Andres Acosta, Carel Le Roux and Bart Van Der Schueren discuss precision medicine for #obesity on Wednesday 14 May 11:30-13:00 in Conference Room 3 📅 See more here: imisophia.eu/ECO-2025-previ…